Griseofulviin (microsize)
NDC Package 42254-306-04

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Griseofulviin (microsize) is major indications for Griseofulvin Oral Suspension are:Griseofulvin inhibits the growth of those genera of fungi that commonly cause ringworm infections of the hair, skin, and nails, such as:Note: Prior to therapy, the type of fungi responsible for the infection should be identified. Marketed by Rebel Distributors Corp, this product is identified by NDC 42254-306 and is authorized under FDA application ANDA065394.

Identification & Billing

NDC Package Code
42254-306-04
Package Description
120 mL in 1 BOTTLE
Product Code
42254-306
11-Digit Billing Format
42254030604
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
Units Per Package
120 ML
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Griseofulviin (microsize)
Dosage Form
-
Usage Information
Major indications for Griseofulvin Oral Suspension are:Griseofulvin inhibits the growth of those genera of fungi that commonly cause ringworm infections of the hair, skin, and nails, such as:Note: Prior to therapy, the type of fungi responsible for the infection should be identified. The use of the drug is not justified in minor or trivial infections which will respond to topical antifungal agents alone.It is not effective in:

Regulatory & Marketing

Labeler Name
Rebel Distributors Corp
FDA Application #
ANDA065394
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
07-26-2007
Listing Expiration
12-31-2017
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 42254-306-04 identifies a specific commercial package of 120 ml in 1 bottle of Griseofulviin (microsize), labeled by Rebel Distributors Corp. This product is billed per "ML" milliliter and contains an estimated amount of 120 billable units per package. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Rebel Distributors Corp on July 26, 2007. The current certification is valid through December 31, 2017.

How is this Rebel Distributors Corp product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 42254030604. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. There are 120 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
42254-306-04
11-Digit CMS (5-4-2)
42254-0306-04

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.